选择性消化道去污染国内外研究现状及进展.pdf
http://www.100md.com
第1页 |
参见附件(117kb)。
lial growth factor (VEGF) mRNA splice variant s are dif2
ferentially expressed in human blastocyst s [J ] . Mol Hum
Reprod , 2001 , 7 (1) :57
[5 ] Skobe M , Hawighorst T , Jackson DG, et al . Induction
of tumor lymphangiogenesis by VEGF2C promotes breast
cancer metastasis [J ] . Nat Med , 2001 , 7 (2) :150
[ 6 ] Komuro Y, Udagawa Y, Susumu N , et al . Paclitaxel and
SN238 overcome cisplatin resistance of cell lines by down2
regulating the influx and efflux system of cispaltin [ J ] .
Cancer Res , 2001 , 92 (11) :1242
[7 ] Shimada H , Takeda A , Nabeya Y, et al . Clinical signifi2
cance of serum vascular endothelial growth factor in e2
sophageal squamous cell carcinoma[J ] . Cancer , 2001 , 92
(30) :663
[8 ] Yancopoulos GD , Davis S , Gale NW , et al . Vascular
specific growth factors and blood vessel formation [ J ] .
Nature , 2000 , 407 (6801) :242
[9 ] Brekken RA , Thorpe PE. Vascular endothelial growth
factor and vascular targeting of solid tumors [J ] . Anti2
cancer Res , 2001 , 21 (6B) :4221
[10 ] Toi M , Mat sumoto T , Bando H , et al . Vascular endo2
thelial growth factor : it s prognostic , predicti2ve , and
therapeutic implications[J ] . Lancet Oncol , 2001 , 2 (11) :
667
[11 ] Lai CM , Brankov M , Zaknich T , et al . Inhibition of an2
giogenesis by adenovirus2mediated sFlt21 expression in a
rat model of corneal neovasculari2zation [J ] . Hum Gene
Ther , 2001 , 12 (10) :1299
[12 ] Carmeliet P , Collen D. Molecular basis of angiog2enesis
role of VEGF and VE2cadherin [J ] . Ann N Y Acad Sci ,2000 , 902 :249
[13 ] Mandriota SJ , J ussila L , J elt sch M , et al . Vascular en2
dothelial growth factor2C2mediated lymphangi2 ogenesis
promotes tumor metastasis [J ] . EMBO J , 2001 , 20 (4) :
672
[14 ] Karpanen T , Egeblad M , Karkkainen MJ . Vascular en2
dothelial growth factor C promotes tumor lymphangio2
genesis and int ralymphatic tumor growth [ J ] . Cancer
Res , 2001 , 61 (5) :1786
[15 ] Kurebayashi J , Ot suki T , Kunisue H , et al . Expression
of vascular endothelial growth factor ( VEGF ) family
members in breast cancer [J ] . Jpn J Cancer Res , 1999 ,90 (9) :997
[16 ] Kajita T , Ohta Y, Kimura K, et al , The expression of
vascular endothelial growth factor C and it s receptors in
non2samll cell lung cancer [J ] . Br J Cancer , 2001 , 85
(2) :225
[ 17 ] Furudoi A , Tanaka S , Haruma K, et al . Clinical signifi2
cancer of vascular endothelial growt factor C expression
and angiogenesis at the deepest invasive site of advanced
colorectal carcinoma [J ] . Oncology , 2002 , 62 (2) :157
[18 ] Padera TP , Kadambi A , Tomaso ED , et al . Lymphatic
metastasis in the absencer of functional int ratumor lym2
phatics[J ] . Sciencer , 2002 , 296 (5574) :1883
[19 ] Williams CS , Leek RD , Robson AM , et al . Absence of
lymphangiogenesis and int ratumoral lymph vessels in hu2
man metastatic breast cancer [J ] . J Pathol , 2003 , 200
(2) :195
[20 ] He Y, Kozaki K, Karpanen T , et al . Suppression of
tumor lymphangiogenesis and lymph node metastasis by
blocking vascular endothelial growth factor receptor 3
signaling[J ] . J Natl Cancer Inst , 2002 , 94 (11) :819
[21 ] J ain RK, Padera TP. Prevention and t reatment of lym2
phatic metastasis by antilymphangiogenic therapy [J ] . J ......
ferentially expressed in human blastocyst s [J ] . Mol Hum
Reprod , 2001 , 7 (1) :57
[5 ] Skobe M , Hawighorst T , Jackson DG, et al . Induction
of tumor lymphangiogenesis by VEGF2C promotes breast
cancer metastasis [J ] . Nat Med , 2001 , 7 (2) :150
[ 6 ] Komuro Y, Udagawa Y, Susumu N , et al . Paclitaxel and
SN238 overcome cisplatin resistance of cell lines by down2
regulating the influx and efflux system of cispaltin [ J ] .
Cancer Res , 2001 , 92 (11) :1242
[7 ] Shimada H , Takeda A , Nabeya Y, et al . Clinical signifi2
cance of serum vascular endothelial growth factor in e2
sophageal squamous cell carcinoma[J ] . Cancer , 2001 , 92
(30) :663
[8 ] Yancopoulos GD , Davis S , Gale NW , et al . Vascular
specific growth factors and blood vessel formation [ J ] .
Nature , 2000 , 407 (6801) :242
[9 ] Brekken RA , Thorpe PE. Vascular endothelial growth
factor and vascular targeting of solid tumors [J ] . Anti2
cancer Res , 2001 , 21 (6B) :4221
[10 ] Toi M , Mat sumoto T , Bando H , et al . Vascular endo2
thelial growth factor : it s prognostic , predicti2ve , and
therapeutic implications[J ] . Lancet Oncol , 2001 , 2 (11) :
667
[11 ] Lai CM , Brankov M , Zaknich T , et al . Inhibition of an2
giogenesis by adenovirus2mediated sFlt21 expression in a
rat model of corneal neovasculari2zation [J ] . Hum Gene
Ther , 2001 , 12 (10) :1299
[12 ] Carmeliet P , Collen D. Molecular basis of angiog2enesis
role of VEGF and VE2cadherin [J ] . Ann N Y Acad Sci ,2000 , 902 :249
[13 ] Mandriota SJ , J ussila L , J elt sch M , et al . Vascular en2
dothelial growth factor2C2mediated lymphangi2 ogenesis
promotes tumor metastasis [J ] . EMBO J , 2001 , 20 (4) :
672
[14 ] Karpanen T , Egeblad M , Karkkainen MJ . Vascular en2
dothelial growth factor C promotes tumor lymphangio2
genesis and int ralymphatic tumor growth [ J ] . Cancer
Res , 2001 , 61 (5) :1786
[15 ] Kurebayashi J , Ot suki T , Kunisue H , et al . Expression
of vascular endothelial growth factor ( VEGF ) family
members in breast cancer [J ] . Jpn J Cancer Res , 1999 ,90 (9) :997
[16 ] Kajita T , Ohta Y, Kimura K, et al , The expression of
vascular endothelial growth factor C and it s receptors in
non2samll cell lung cancer [J ] . Br J Cancer , 2001 , 85
(2) :225
[ 17 ] Furudoi A , Tanaka S , Haruma K, et al . Clinical signifi2
cancer of vascular endothelial growt factor C expression
and angiogenesis at the deepest invasive site of advanced
colorectal carcinoma [J ] . Oncology , 2002 , 62 (2) :157
[18 ] Padera TP , Kadambi A , Tomaso ED , et al . Lymphatic
metastasis in the absencer of functional int ratumor lym2
phatics[J ] . Sciencer , 2002 , 296 (5574) :1883
[19 ] Williams CS , Leek RD , Robson AM , et al . Absence of
lymphangiogenesis and int ratumoral lymph vessels in hu2
man metastatic breast cancer [J ] . J Pathol , 2003 , 200
(2) :195
[20 ] He Y, Kozaki K, Karpanen T , et al . Suppression of
tumor lymphangiogenesis and lymph node metastasis by
blocking vascular endothelial growth factor receptor 3
signaling[J ] . J Natl Cancer Inst , 2002 , 94 (11) :819
[21 ] J ain RK, Padera TP. Prevention and t reatment of lym2
phatic metastasis by antilymphangiogenic therapy [J ] . J ......
您现在查看是摘要介绍页,详见PDF附件(117KB,3页)。